메뉴 건너뛰기




Volumn 67, Issue 1, 2016, Pages 165-166

New Potassium Binders: A Call to Test Their Efficacy and Safety in Dialysis Patients

Author keywords

[No Author keywords available]

Indexed keywords

PATIROMER; POTASSIUM; SODIUM ZIRCONIUM CYCLOSILICATE; POLYMER; SILICATE; ZS-9 COMPOUND;

EID: 84954451006     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2015.09.029     Document Type: Letter
Times cited : (5)

References (7)
  • 1
    • 84914703676 scopus 로고    scopus 로고
    • Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: The HARMONIZE randomized clinical trial
    • M. Kosiborod, H.S. Rasmussen, P. Lavin, and et al. Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial JAMA 312 21 2014 2223 2233
    • (2014) JAMA , vol.312 , Issue.21 , pp. 2223-2233
    • Kosiborod, M.1    Rasmussen, H.S.2    Lavin, P.3
  • 2
    • 84920982556 scopus 로고    scopus 로고
    • Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors
    • M.R. Weir, G.L. Bakris, D.A. Bushinsky, and et al. Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors N Engl J Med 372 3 2015 211 221
    • (2015) N Engl J Med , vol.372 , Issue.3 , pp. 211-221
    • Weir, M.R.1    Bakris, G.L.2    Bushinsky, D.A.3
  • 3
    • 84937401175 scopus 로고    scopus 로고
    • Effect of patiromer on serum potassium level in patients with hyperkalemia and diabetic kidney disease: The AMETHYST-DN randomized clinical trial
    • G.L. Bakris, B. Pitt, M.R. Weir, and et al. Effect of patiromer on serum potassium level in patients with hyperkalemia and diabetic kidney disease: the AMETHYST-DN randomized clinical trial JAMA 314 2 2015 151 161
    • (2015) JAMA , vol.314 , Issue.2 , pp. 151-161
    • Bakris, G.L.1    Pitt, B.2    Weir, M.R.3
  • 4
    • 84884698656 scopus 로고    scopus 로고
    • Potassium balance in dialysis patients
    • S. Sanghavi, S. Whiting, and J. Uribarri Potassium balance in dialysis patients Semin Dial 26 5 2013 597 603
    • (2013) Semin Dial , vol.26 , Issue.5 , pp. 597-603
    • Sanghavi, S.1    Whiting, S.2    Uribarri, J.3
  • 5
    • 84937513373 scopus 로고    scopus 로고
    • Dialysate and serum potassium in hemodialysis
    • A.M. Hung, and R.M. Hakim Dialysate and serum potassium in hemodialysis Am J Kidney Dis 66 1 2015 125 132
    • (2015) Am J Kidney Dis , vol.66 , Issue.1 , pp. 125-132
    • Hung, A.M.1    Hakim, R.M.2
  • 6
    • 34548857930 scopus 로고    scopus 로고
    • Serum and dialysate potassium concentrations and survival in hemodialysis patients
    • C.P. Kovesdy, D.L. Regidor, R. Mehrotra, and et al. Serum and dialysate potassium concentrations and survival in hemodialysis patients Clin J Am Soc Nephrol 2 5 2007 999 1007
    • (2007) Clin J Am Soc Nephrol , vol.2 , Issue.5 , pp. 999-1007
    • Kovesdy, C.P.1    Regidor, D.L.2    Mehrotra, R.3
  • 7
    • 67649889627 scopus 로고    scopus 로고
    • Cardiovascular protection with antihypertensive drugs in dialysis patients: Systematic review and meta-analysis
    • R. Agarwal, and A.D. Sinha Cardiovascular protection with antihypertensive drugs in dialysis patients: systematic review and meta-analysis Hypertension 53 5 2009 860 866
    • (2009) Hypertension , vol.53 , Issue.5 , pp. 860-866
    • Agarwal, R.1    Sinha, A.D.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.